" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

CSO Leadership Series: Judy Dunn, Global Head Clinical Development, Roche


Thursday, September 11, 2014 from 8:30 AM to 10:00 AM (EDT)

CSO Leadership Series: Judy Dunn, Global Head Clinical...

Ticket Information

Ticket Type Sales End Price Fee Quantity
NewYorkBIO Member (Sept 11/Judy Dunn only) Ended $65.00 $4.57
NewYorkBIO Member--Full series (4 events)
Full series subscription to 4 CSO Leadership events. Save $20 off individual event rate.
Ended $240.00 $14.19
Future Member (Sept 11/Judy Dunn only)
Non-member registration is limited.
Ended $95.00 $6.22

Who's Going

Loading your connections...

Share CSO Leadership Series: Judy Dunn, Global Head Clinical Development, Roche

Event Details

Chief Science Officers and Chief Medical Officers have a tough job—organizing and managing R&D uncovering new disruptive discovery and development models; assessing the impact of pricing, reimbursement, and regulation—all while raising capital, working with investors, and strategizing appropriate exits.

NewYorkBIO’s CSO Leadership Series is designed to help bioscience CSO/CMOs to engage with experienced industry leaders and address the unique challenges associated with the job. Attendees will gain guidance on strategic planning, exit planning, and insight into the trends affecting the future of medical research in the emerging life science space

Limited to 25 attendees, the CSO Leadership Series is restricted to life science executives (no service providers beyond the sponsor) and will offer a unique opportunity to hear directly from—and to network with—New York’s life science leadership.


Exclusive CEO Leadership Series Sponsor




September 11, 2014

Judith Dunn, PhD

VP, Global Head Clinical Development

Head of Roche Innovation Center, New York City

Judy joined Roche in 2010 as part of PD Neuroscience. She founded the Development Integration Team which facilitates early scientific collaboration between the REDs and PD. Judy moved to pRED in 2013 to Head the Roche Innovation Center New York, and in 2014 she assumed the role of Global Head of Clinical Development. Prior to Roche, Judy held positions in the research and commercial divisions of Pfizer, led Psychiatry Clinical Development at Sepracor, and served as Vice President of Clinical Research at Flexion, a biotech company. Judy has a keen interest in methodology and holds leadership positions in several external societies focused on improving the drug development paradigm. Judy attended Wesleyan University and the University of Rochester, obtaining undergraduate and graduate degrees in Neurobiology. She was recipient of a Research Fellowship in Neuropharmacology from the Center for Brain Research at Strong Memorial Hospital as well as a Postdoctoral Fellowship in Clinical Research from Pfizer.


Have questions about CSO Leadership Series: Judy Dunn, Global Head Clinical Development, Roche? Contact NewYorkBIO

When & Where

Alexandria Center for Life Science
Offices of Kadmon Pharmaceuticals, 5th Floor Conference Room
450 E 29th St
New York, NY 10016

Thursday, September 11, 2014 from 8:30 AM to 10:00 AM (EDT)

  Add to my calendar



NewYorkBIO is the life science trade association of New York, dedicated to the development and growth of New York State-based bioscience-related industries and institutions, and to strengthening the competitiveness of New York State as a premier global location for biotechnology/biomedical research, education and industry.

Through our membership of over 200 bioscience companies, world class research institutes, and related professional services biotechnology professionals are able to access the information, resources and assistance they need to make their ventures a success.

  Contact the Organizer
CSO Leadership Series: Judy Dunn, Global Head Clinical Development, Roche
New York, NY Events Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.